GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » EPS (Basic)

Biovica International AB (STU:9II) EPS (Basic) : €-0.10 (TTM As of Jan. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Biovica International AB EPS (Basic)?

Biovica International AB's basic earnings per share (Basic EPS) for the three months ended in Jan. 2025 was €-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2025 was €-0.10.

Biovica International AB's EPS (Diluted) for the three months ended in Jan. 2025 was €-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was €-0.10.

Biovica International AB's EPS without NRI for the three months ended in Jan. 2025 was €-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2025 was -0.10.

During the past 3 years, the average EPS without NRI Growth Rate was -15.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Biovica International AB's highest 3-Year average EPS without NRI Growth Rate was -11.70% per year. The lowest was -54.00% per year. And the median was -20.00% per year.


Biovica International AB EPS (Basic) Historical Data

The historical data trend for Biovica International AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EPS (Basic) Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -0.14 -0.20 -0.28 -0.18

Biovica International AB Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.02 -0.02 -0.02

Biovica International AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biovica International AB's Basic EPS for the fiscal year that ended in Apr. 2024 is calculated as

Basic EPS (A: Apr. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-10.756-0)/58.408
=-0.18

Biovica International AB's Basic EPS for the quarter that ended in Jan. 2025 is calculated as

Basic EPS (Q: Jan. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.988-0)/97.786
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (STU:9II) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Biovica International AB EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines